TB
TrueBlue, Inc.
TBI · NYSE
$9.80 -1.41% (-$0.14)
1M -8.66%
Market Cap $279.7M
P/E Ratio -
Div. Yield -
ROE 20.78%
Bulios Fair Price
$5.09
48.1% downside
Current Price
$9.8
Undervalued Fair Value Overvalued
According to Bulios Fair Price, TBI is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.17x
P/B 1.10x
P/E N/A
Growth
0 /100
Declining Rev. growth 10.50%
Book val. growth 17.91%
EPS growth N/A
Profitability
6 /100
Weak Gross margin 20.49%
Net margin 3.35%
FCF margin 3.99%
Quality
15 /100
Poor ROIC 5.36%
ROE 20.78%
Asset turnover 2.71x
Debt
60 /100
Moderate Debt/Equity 0.54x
Current ratio 2.28x
Int. coverage -20.93x
Stability
31 /100
Unstable Beta 1.67x
Rev. volatility 11.44%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TBI
Online
Sector
Industrials
Industry
Staffing & Employment Services
CEO
Taryn R. Owen
Employees
3,500
Headquarters
Tacoma
Upcoming events
02 NOV
Earnings
Upcoming earnings report